Skip to main content
. 2016 Aug 22;7(41):66769–66775. doi: 10.18632/oncotarget.11484

Figure 1. ASC-J9® reduces prostatitis in the NOD mouse.

Figure 1

(A) The scheme shows the time frame of mouse treatment. (B) H&E staining of representative prostate sections from ASC-J9® or vehicle control treated NOD mice. A progressively increasing lymphomonuclear cell infiltrate is apparent (arrow). Mean numbers ± SEM of intraprostatic infiltrates/cross section are reported. The statistic analyses were performed using Student t test. Each bar represents the mean ± sem. **P < 0.01.